Predicting the next round of drugs for Medicare price negotiation.
Predicting the next round of drugs for Medicare price negotiation.
Matthew Vogel,Adam Tellier,Rena M. Conti
2024 · DOI: 10.1126/scitranslmed.adq5711
Science Translational Medicine · 1 Citations
TLDR
The process that will be used to select the next 15 drugs for price negotiation by Medicare in 2025 is analyzed.
Abstract
There is uncertainty regarding which brand-name prescription drugs will have their prices negotiated by Medicare in 2025. This Viewpoint analyzes the process that will be used to select the next 15 drugs for price negotiation.